Bit also stated in it's 12 May 2023 Announcement:
"As previously advised (ASX announcement 4 May 2023 contained details of the trial), Biotron has commenced a Phase 2, double blind, placebo-controlled clinical trial (BIT225-012) to determine if 7 days of treatment with BIT225 commenced within 3 days of onset of COVID19 symptoms results in reduction in SARS-CoV-2 blood viral load, clinically favourable changes in viral, inflammatory and immune activation markers, as well as improvement in clinical symptoms of COVID-19."
Bit also stated in it's 12 May 2023 Announcement: "As previously...
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.0¢ | 1.9¢ | $11.47K | 600.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 1164218 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 794509 | 8 |
View Market Depth
| Last trade - 11.55am 19/11/2024 (20 minute delay) ? |
| BIT (ASX) Chart |